<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Neuroscience Physiology and Pharmacology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D792CC11-5259-4B4A-9F3F-097BF56072F8"><gtr:id>D792CC11-5259-4B4A-9F3F-097BF56072F8</gtr:id><gtr:firstName>Josef</gtr:firstName><gtr:otherNames>Thomas</gtr:otherNames><gtr:surname>Kittler</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802377"><gtr:id>7A139AF7-921F-4494-98E6-0361CC26DC48</gtr:id><gtr:title>Regulation of synaptic inhibition by GABAA receptor trafficking under normal conditions and in neurological and neuropsy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802377</gtr:grantReference><gtr:abstractText>Nerve cells send signals to each other by releasing chemicals called neurotransmitters at special sites called synapses. The neurotransmitters act on special proteins (receptors), allowing ions to cross the cell membrane, thus producing voltage changes across the membrane. My application is on two key aspects of brain function: (i) how neurons regulate the number of neurotransmitter receptor proteins present at synapses to control the size of the membrane voltage changes; and (ii) how this regulation may be altered in disease processes. Studying the molecular mechanisms that underlie these regulatory processes will allow us to understand better how the brain works under healthy conditions, and how dysregulation of these processes leads to altered electrical behaviour of nerve cells in disease. This work could lead the way to the development of new therapies in devastating diseases such as epilepsy, stroke, anxiety, Huntington?s disease, substance abuse, depression, Parkinson?s disease and autism.</gtr:abstractText><gtr:technicalSummary>The activity of GABAA receptors (GABAARs)s at inhibitory synapses is critical for maintaining the correct balance between excitation and inhibition of neurons. The strength of inhibitory synapses, and thus neural information processing, can be modulated by altering the trafficking of GABAARs into or out of the postsynaptic membrane. Altered GABAAR activity and trafficking are also implicated in many neurological and psychiatric diseases including epilepsy, stroke, Huntington?s disease, anxiety, drug addiction, depression and schizophrenia. Thus, understanding how the strength of inhibitory synapses is controlled by GABAAR trafficking is crucial for understanding how the brain works, and may also lead to the identification of therapeutic interventions in a wide range of diseases. 
Using novel imaging, molecular, cell biological and electrophysiological techniques, I will determine the molecular mechanisms that control GABAAR trafficking. I will focus on how covalent modification of GABAARs (e.g. by phosphorylation and ubiquitination) and interaction with GABAAR associated proteins (AP2, HAP1 and the novel ubiquitin ligase, Guapa) regulates surface receptor mobility (lateral diffusion and dwell time at synapses) and GABAAR trafficking to and from the membrane (exocytosis, endocytosis and degradation) to control inhibition under resting conditions, during neural activity, during homeostatic plasticity and in diseases like epilepsy. 
A major aim will be to develop novel imaging techniques to study receptor lateral diffusion and trafficking (such as receptor tracking with Quantum Dots) to study trafficking processes in intact tissues such as brain slices from animal models of neurological disease.
A second major aim will be to determine if the pathological GABAAR internalization that occurs during status epilepticus, which leads to rapid resistance to drugs used to treat status, can be inhibited by targeting the GABAAR endocytic and degradation machineries. This cou lead to novel therapeutic interventions for this devastating disease. 
A third major aim will be to determine if HAP1-dependent GABAAR trafficking is important for inhibitory homeostatic plasticity, to test whether this is disrupted by mutant huntingtin (which causes Huntington?s disease) and to determine whether HAP1 function is regulated by the schizophrenia susceptibility genes DISC1 and dysbindin. 
This work will provide fundamental insights into the mechanisms that regulate the number of GABAA receptors at synapses normally and during synaptic plasticity, and may also lead to new information regarding the cell biology of a number of proteins critically implicated in neurological and psychiatric diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2015-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1933793</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Computer Science</gtr:department><gtr:description>Developing techniques for studying receptor membrane dynamics with single molecule Quantum Dot imaging</gtr:description><gtr:id>BFC3D978-B594-4256-A001-D6E66A88B5F5</gtr:id><gtr:impact>Data from this collaboration has been presented at several international meetings. These approaches have lead to new findings regarding the membrane dynamics of GABA-A receptors recently published - Muir et al., 2010 PNAS</gtr:impact><gtr:outcomeId>YVgodM5toJi-1</gtr:outcomeId><gtr:partnerContribution>Allowed the development and application of computer vision techniques to imaging and analysis of single molecule tracking of Quantum Dots</gtr:partnerContribution><gtr:piContribution>Application of nanotechnology to receptor imaging. Developed platform for imaging signals from Quantum Dot labelled GABA-A receptors.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute for Ageing and Health</gtr:department><gtr:description>Neuromouse consortium - Doug Turnbull</gtr:description><gtr:id>DFEBFC49-D8F7-49EB-B67F-1E4494B02879</gtr:id><gtr:impact>Lead to succesfull MRC mouse consortium bid.</gtr:impact><gtr:outcomeId>EoueCkAQFSQ-1</gtr:outcomeId><gtr:partnerContribution>Neuromouse consortium will provide access to novel mouse transgenic lines and access to phenotyping expertise.</gtr:partnerContribution><gtr:piContribution>Contributing member of Neuromouse consortium bid for generation and phentoyping of novel mouse lines relevant to human disease which was recently awarded.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>Imaging receptor membrane dynamics with Quantum Dots</gtr:description><gtr:id>25ACBA7F-B39D-4E24-9201-757B6B39E542</gtr:id><gtr:impact>Data from this collaboration has been presented at several international meetings. Data currently being written up for publication. The methods derived from this collaboration directly contributed to a successful application for an MRC Senior Non-Clinical Fellowship</gtr:impact><gtr:outcomeId>616832E4F39-1</gtr:outcomeId><gtr:partnerContribution>Provided novel methods for acquisition and analysis of ion channels at the membrane of nerve cell labelled with semi conductor nanocrystals</gtr:partnerContribution><gtr:piContribution>Lead research on receptor membrane dynamics in nerve cell membranes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Pfizer</gtr:description><gtr:id>E31C22C3-A83B-4436-AFFB-334B48398504</gtr:id><gtr:impact>Commitment from Pfizer to financial support and provision of proprietary reagents for future work leading to successful award of an MRC Case studentship. in form of MRC case studentship application - pending</gtr:impact><gtr:outcomeId>ENiE5DBvKpg-1</gtr:outcomeId><gtr:partnerContribution>Commitment from Pfizer to financial support and provision of proprietary reagents for future work in form of MRC case studentship application - pending</gtr:partnerContribution><gtr:piContribution>Expertise in imaging and neurobiology</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neuroscience, Physiology &amp; Pharmacology</gtr:department><gtr:description>Collaboration on the function of Disc1 and PCM1 in Schizophrenia and major mental illness</gtr:description><gtr:id>4022564B-37F1-4C8A-ADA7-FF2C6532215B</gtr:id><gtr:impact>Joint application for an MRC programme grant (Hugh Gurling lead PI).</gtr:impact><gtr:outcomeId>VdfEAWYx3Nq-1</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided important expertise in human molecular genetics</gtr:partnerContribution><gtr:piContribution>Analysis of neuronal function of Schizophrenia susceptibility genes Disc1 and PCM1</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life and Medical Sciences</gtr:department><gtr:description>Collaboration with Matthew Walker</gtr:description><gtr:id>11CF34C2-1CE5-4E1E-8E8A-16D71A3AB0A6</gtr:id><gtr:impact>Joint publication</gtr:impact><gtr:outcomeId>5461177640ca08.28358121-1</gtr:outcomeId><gtr:partnerContribution>Providing expertise on rodent and in vitro models of epilepsy</gtr:partnerContribution><gtr:piContribution>Providing high resolution microscopy imaging expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>In2Science UK</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>05E1C651-2BCE-4E96-9CF7-49285A15E000</gtr:id><gtr:impact>1-2 week laboratory placement scheme in the summer for gifted A-level science students from disadvantaged backgrounds (the poorest 10% of our society).

Stimulated thinking of future young scientist</gtr:impact><gtr:outcomeId>54621f57efa150.99684719</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participated in In2Science UK</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>27E2D8F2-6AC8-4627-A6A4-9293792A1B95</gtr:id><gtr:impact>1-2 week laboratory placement scheme in the summer for gifted A-level science students from disadvantaged backgrounds (the poorest 10% of our society).


Impacted on students interest in biomedical research.</gtr:impact><gtr:outcomeId>crmSndSB8a5</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation and Gold Medal Winner House of Commons SET for Britain</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5B34C3F2-FD20-4C00-9799-9EEF6B7FC59B</gtr:id><gtr:impact>SET for Britain is a competition in the House of Commons which involves researchers displaying posters of their work to panels of expert judges and more than 100 MPs. The event aims to help politicians understand more about the UK's thriving science base and rewards some of the strongest scientific research being undertaken in the UK.


Dr Atkin won the Gold Prize Medal for her presentation. This is also lead to some media interest</gtr:impact><gtr:outcomeId>iTF5uD9tpML</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newsletter article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>5EF1E04A-2D16-444F-AAF7-E7C69C2D70EF</gtr:id><gtr:impact>Twelvetrees AE, Yuen EY, Arancibia-Carcamo IL, Rostaing P, Lumb MJ, Triller A, Saudou F, Yan Z, Kittler JT (2010) Delivery of GABAA receptors to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron. 65:53-65. Journal impact factor 14.2 (Web of Science 2008).

This paper, details for the first time the mechanisms that underlie the rapid delivery of inhibitory GABAA receptors to synapses. The work shows that a motor protein complex consisting of microtubule motors and an adaptor protein called the huntingtin associated protein 1 (HAP1) deliver GABAA receptor transport vesicles to inhibitory synapses to change the strength of these synapses. The study also reveals that when the HAP1 interacting partner huntingtin is mutated, as in Huntington's disease, GABAA receptor transport is impaired which may contribute to altered information processing in Huntington's. This work was highlighted in the April issue of the MRC bi-monthly magazine MRC Network (http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006687).

None</gtr:impact><gtr:outcomeId>mLNq24JhK5g</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Website dissemination</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>676085BD-F21B-44CC-BD27-E5315363D368</gtr:id><gtr:impact>Twelvetrees AE, Yuen EY, Arancibia-Carcamo IL, Rostaing P, Lumb MJ, Triller A, Saudou F, Yan Z, Kittler JT (2010) Delivery of GABAA receptors to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron. 65:53-65. Journal impact factor 14.2 (Web of Science 2008).

This paper, details for the first time the mechanisms that underlie the rapid delivery of inhibitory GABAA receptors to synapses. The work shows that a motor protein complex consisting of microtubule motors and an adaptor protein called the huntingtin associated protein 1 (HAP1) deliver GABAA receptor transport vesicles to inhibitory synapses to change the strength of these synapses. The study also reveals that when the HAP1 interacting partner huntingtin is mutated, as in Huntington's disease, GABAA receptor transport is impaired which may contribute to altered information processing in Huntington's. This work was highlighted on the UCL website (http://www.ucl.ac.uk/news/news-articles/from-neuroscience/10012001).

N/A</gtr:impact><gtr:outcomeId>MX4xAPNo2ii</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Case Award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D1DE782F-C3EC-41C5-9616-46C831BC779F</gtr:id><gtr:outcomeId>SpVy1eXdiJk0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Funding allowed us to continue to develop in my group of state of the art imaging approaches to study the behavior of single neurotransmitter receptors in the plasma membrane of nerve cells. These approaches used novel technologies such as semi conductor nanocrystals (Quantum Dots).</gtr:description><gtr:id>7715A9C4-6350-4D56-ABE2-A7273DCFAA6C</gtr:id><gtr:impact>This approach was used to study receptor membrane dynamics as described in our recent publication: Muir et al., 2010 PNAS.</gtr:impact><gtr:outcomeId>fqH5AHsubg1</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Single molecule imaging with Quantum Dots</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6CB449EA-E78B-4C44-B950-D8BBB5F13EEC</gtr:id><gtr:title>Control of mitochondrial transport and localization in neurons.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b47a4311b842d7252f7aaef68365931"><gtr:id>5b47a4311b842d7252f7aaef68365931</gtr:id><gtr:otherNames>MacAskill AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>pm_15928_28_20006503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85A64E44-5B32-48BC-A424-D2A4648B41AC</gtr:id><gtr:title>GABAergic signaling in health and disease.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14dee18bd70ccf8183d1f55e223f1991"><gtr:id>14dee18bd70ccf8183d1f55e223f1991</gtr:id><gtr:otherNames>McBain CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>58ca44a4b17d77.11676692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13A72A89-2D2D-4759-A085-61A3025F701A</gtr:id><gtr:title>Preface. Trafficking of organelles and proteins in the nervous system.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78ba22c60391546c97600ad15e38b285"><gtr:id>78ba22c60391546c97600ad15e38b285</gtr:id><gtr:otherNames>Couve A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>545f8f2b497db2.49713000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12E72DEF-ED1C-4FC8-BD53-B050FDE1961B</gtr:id><gtr:title>Miro1 Regulates Activity-Driven Positioning of Mitochondria within Astrocytic Processes Apposed to Synapses to Regulate Intracellular Calcium Signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d88472f82acf9b5475f0b4c982d64b08"><gtr:id>d88472f82acf9b5475f0b4c982d64b08</gtr:id><gtr:otherNames>Stephen TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>56e15a1a490e92.49326061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0385596-A7ED-4E67-896A-0452F591FCCF</gtr:id><gtr:title>Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35e943df489a9715b794911a3bf46aa7"><gtr:id>35e943df489a9715b794911a3bf46aa7</gtr:id><gtr:otherNames>Atkin TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>58ca44a5176942.72506739</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B293FA50-C452-4442-BF4D-06F92B8B7380</gtr:id><gtr:title>Shank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanism.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/163e30d9f20b2f525cb7223716173a50"><gtr:id>163e30d9f20b2f525cb7223716173a50</gtr:id><gtr:otherNames>Duffney LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>545f8f2bc19462.32555241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE371058-F98A-4ECD-AC0B-49947C8C1E93</gtr:id><gtr:title>An Essential Role for the Tetraspanin LHFPL4 in the Cell-Type-Specific Targeting and Clustering of Synaptic GABAReceptors.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd68ffb6b25c51d2e065056598220f1e"><gtr:id>cd68ffb6b25c51d2e065056598220f1e</gtr:id><gtr:otherNames>Davenport EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2fd742e4a600.24030055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E1EAD0B-AD10-4453-BF52-E34F9B946918</gtr:id><gtr:title>Neuronal activity mediated regulation of glutamate transporter GLT-1 surface diffusion in rat astrocytes in dissociated and slice cultures.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38bdf9bd7ecbf11612ce582a6d1553ba"><gtr:id>38bdf9bd7ecbf11612ce582a6d1553ba</gtr:id><gtr:otherNames>Al Awabdh S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>573ed0876744a4.44540800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C06AC695-D281-47A5-A308-4BC1C1DE21E4</gtr:id><gtr:title>The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0317dba5f96c404e352da870c56a66ff"><gtr:id>0317dba5f96c404e352da870c56a66ff</gtr:id><gtr:otherNames>Pathania M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>545f8f2b74c313.48038151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2F16101-42B9-4E06-A9DF-0948C0BEE4CA</gtr:id><gtr:title>Continuous hydrothermal synthesis of surface-functionalised nanophosphors for biological imaging</gtr:title><gtr:parentPublicationTitle>RSC Advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3fb2f8ffa6240320c4edcd845db6b48"><gtr:id>a3fb2f8ffa6240320c4edcd845db6b48</gtr:id><gtr:otherNames>Gruar R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>58ca44a4de1e15.17601805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB8D6ABC-8CBC-4819-B9D8-61BC35ABF0CA</gtr:id><gtr:title>DISC1 and the aggresome: a disruption to cellular function?</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f06924555d8c36055f9f2920389ec90"><gtr:id>3f06924555d8c36055f9f2920389ec90</gtr:id><gtr:otherNames>Atkin T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>545f8f2b998735.97353104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0652AEB8-760E-4F3E-AF05-472EABFAF626</gtr:id><gtr:title>Activation of calcineurin underlies altered trafficking of a2 subunit containing GABAA receptors during prolonged epileptiform activity.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47b28e98ac4e57a855cc7b7e54d590c3"><gtr:id>47b28e98ac4e57a855cc7b7e54d590c3</gtr:id><gtr:otherNames>Eckel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>545f8f2ac0b4a5.51318535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83E72A62-8CD6-41B3-AD91-B234809D1DB5</gtr:id><gtr:title>NMDA receptors regulate GABAA receptor lateral mobility and clustering at inhibitory synapses through serine 327 on the ?2 subunit.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1f172803ad77a2a70610c2c2488b4ed"><gtr:id>f1f172803ad77a2a70610c2c2488b4ed</gtr:id><gtr:otherNames>Muir J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>EyZvYdwzohB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>504A2FC1-E478-4A3D-817F-FAF369F707ED</gtr:id><gtr:title>Loss of Dendritic Complexity Precedes Neurodegeneration in a Mouse Model with Disrupted Mitochondrial Distribution in Mature Dendrites.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a0f13e35e261dcc65ee00c421b60353"><gtr:id>3a0f13e35e261dcc65ee00c421b60353</gtr:id><gtr:otherNames>L?pez-Dom?nech G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58ca4e28455600.68846244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA290FD0-E550-4FAB-B1C5-7158BEA5AA44</gtr:id><gtr:title>Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b47a4311b842d7252f7aaef68365931"><gtr:id>5b47a4311b842d7252f7aaef68365931</gtr:id><gtr:otherNames>MacAskill AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>SXeUkfuyV48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9515963-0516-46A9-9439-D2734D080A71</gtr:id><gtr:title>DISC1-dependent Regulation of Mitochondrial Dynamics Controls the Morphogenesis of Complex Neuronal Dendrites.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07defecec886b3695a45d7273fc55f74"><gtr:id>07defecec886b3695a45d7273fc55f74</gtr:id><gtr:otherNames>Norkett R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56e159f39c2182.17862598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79A04FBA-1159-412F-849B-53C4F7DA0EB9</gtr:id><gtr:title>Plasticity of GABAA receptor diffusion dynamics at the axon initial segment.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1f172803ad77a2a70610c2c2488b4ed"><gtr:id>f1f172803ad77a2a70610c2c2488b4ed</gtr:id><gtr:otherNames>Muir J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1662-5102</gtr:issn><gtr:outcomeId>545f8f2b21bb75.40589337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7695C24A-9508-4E7A-9B32-2DD1DA26B109</gtr:id><gtr:title>Disrupted in Schizophrenia 1 forms pathological aggresomes that disrupt its function in intracellular transport.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35e943df489a9715b794911a3bf46aa7"><gtr:id>35e943df489a9715b794911a3bf46aa7</gtr:id><gtr:otherNames>Atkin TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15928_28_22291444</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D441B663-F1EC-45AE-B2BB-E4787A2AE846</gtr:id><gtr:title>Impaired alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5826d2ad88413e814f1824ffbf49c543"><gtr:id>5826d2ad88413e814f1824ffbf49c543</gtr:id><gtr:otherNames>Mandal M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>ffcmRMazPbi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38730642-81EF-4373-B5A6-964BF285F6A0</gtr:id><gtr:title>The receptor subunits generating NMDA receptor mediated currents in oligodendrocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a13555c2e2559fc15e04b2dc79679878"><gtr:id>a13555c2e2559fc15e04b2dc79679878</gtr:id><gtr:otherNames>Burzomato V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>Uu9ED2byiiC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5E9205A-6E9D-441F-8EB6-5D391AF782AC</gtr:id><gtr:title>Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4749af4d26cdcc19459c421f3b15c9b5"><gtr:id>4749af4d26cdcc19459c421f3b15c9b5</gtr:id><gtr:otherNames>Twelvetrees AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>jB1CFuFF5cJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEC19415-46DF-4039-BC19-DFF204ABF143</gtr:id><gtr:title>Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af2d5f2e04b285bdff9667c446ba5cae"><gtr:id>af2d5f2e04b285bdff9667c446ba5cae</gtr:id><gtr:otherNames>Birsa N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>54611d46c46109.73427898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCCF3209-5208-4C10-A02C-8FA2CF8E3A32</gtr:id><gtr:title>The cell biology of synaptic inhibition in health and disease.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3375e9a835923724668c6c34d1f7707"><gtr:id>e3375e9a835923724668c6c34d1f7707</gtr:id><gtr:otherNames>Smith KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn><gtr:outcomeId>dXM7HcFiD6H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1B65D45-2F0C-4B89-9DBF-EE406A051855</gtr:id><gtr:title>Identification and characterisation of a Maf1/Macoco protein complex that interacts with GABAA receptors in neurons.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3375e9a835923724668c6c34d1f7707"><gtr:id>e3375e9a835923724668c6c34d1f7707</gtr:id><gtr:otherNames>Smith KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>L2sefHqMqF1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>027B24E8-B3C9-4BA7-9694-2B5453B4F83E</gtr:id><gtr:title>Stabilization of GABA(A) receptors at endocytic zones is mediated by an AP2 binding motif within the GABA(A) receptor ?3 subunit.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3375e9a835923724668c6c34d1f7707"><gtr:id>e3375e9a835923724668c6c34d1f7707</gtr:id><gtr:otherNames>Smith KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_15928_28_22396422</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09E6731F-CBAE-4514-97B6-F81D2C21A3A9</gtr:id><gtr:title>GIT1 and ?PIX are essential for GABA(A) receptor synaptic stability and inhibitory neurotransmission.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3375e9a835923724668c6c34d1f7707"><gtr:id>e3375e9a835923724668c6c34d1f7707</gtr:id><gtr:otherNames>Smith KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545f8f2a97f759.94246419</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802377</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>